Medical Device Outsourcing Market 2022-2027

IMARC Group’s latest report, titled “Medical Device Outsourcing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global medical device outsourcing market reached a value of US$ 105.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 183.13 Billion by 2027, exhibiting a CAGR of 9.10% during 2022-2027. offers a comprehensive analysis of the industry, which comprises insights on the Medical Device Outsourcing Market Demand . The report also includes competitor and regional analysis, and contemporary advancements in the market.

Medical device outsourcing emphasizes contracting with a third party for product design, production, packaging, prototyping, testing, and verification of medical devices in a sterile and regulated environment for the efficient supply chain management. It includes device assembly and packaging for shipment and value-add services, such as package testing and sterilization validation, recurring processing, and process improvement identification. It provides numerous advantages, including minimized manufacturing period, early product introduction into the market, and easy quality check approvals to match regulatory criteria. Additionally, it offers specialized facilities, such as on-site medical labs and cleanrooms, to ensure the production of medical devices is free of contaminants.

Medical Device Outsourcing Market Demand:

The growing need to reduce overhead and operational costs are driving the global market. Coupled with the rising emphasis on maintaining the quality of healthcare services is catalyzing the overall demand for medical device outsourcing across the globe. Furthermore, the increasing government restrictions for obtaining quality certifications are favorably impacting the market. Moreover, the increasing demand for medical equipment in minimally invasive treatments for numerous chronic diseases is creating a positive market outlook. Other factors, such as the growing need for quality healthcare services and extensive research and development (R&D) activities by leading players for enhancing the device’s functioning, are also influencing the market.

Competitive Landscape:

  • Celestica Inc. (Onex Corporation)
  • Charles River Laboratories International Inc
  • Flex Ltd
  • Freyr Inc
  • Heraeus Holding GmbH
  • ICON plc
  • Integer Holdings Corporation
  • IQVIA Inc
  • Plexus Corp
  • Sanmina Corporation,
  • TE Connectivity 
  • West Pharmaceutical Services Inc

Key Market Segmentation:

Breakup by Service:

  • Regulatory Consulting
  • Product Design and Development
  • Product Testing and Sterilization
  • Product Implementation
  • Product Upgrade
  • Product Maintenance

Breakup by Therapeutics:

  • Cardiology
  • Diagnostic Imaging
  • Orthopedic
  • IVD
  • Ophthalmic
  • General and Plastic Surgery
  • Drug Delivery
  • Dental
  • Endoscopy
  • Diabetes Care

Breakup by Application:

  • Class I
  • Class II
  • Class III

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report: 

  • Market Performance (2016-2021)
  • Market Outlook (2022-2027)
  • Porter’s Five Forces Analysis
  • Market Drivers and Success Factors
  • SWOT Analysis
  • Value Chain
  • Comprehensive Mapping of the Competitive Landscape 

Report Coverage:

Report FeaturesDetails
Base Year of the Analysis2021
    Historical Period2016-2021
Forecast Period2022-2027
UnitsUS$ Billion
Segment CoverageService, Therapeutics, Application, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries CoveredUnited States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies CoveredCelestica Inc. (Onex Corporation), Charles River Laboratories International Inc., Flex Ltd., Freyr Inc., Heraeus Holding GmbH, ICON plc, Integer Holdings Corporation, IQVIA Inc., Plexus Corp., Sanmina Corporation, TE Connectivity and West Pharmaceutical Services Inc.
Customization Scope10% Free Customization
Report Price and Purchase OptionSingle User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support10-12 Weeks
Delivery FormatPDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

About Us: 

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. 

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Read More:

By Tate

I am a professional writer and blogger. I’m researching and writing about innovation, Blockchain, technology, business, and the latest Blockchain marketing trends.

Leave a Reply

Your email address will not be published. Required fields are marked *